Anti-AXL Antibody, Mouse Monoclonal (10279-MM17T)

Anti-AXL抗体, Mouse Monoclonal

反应种属:Human
抗原名称:AXL
应用:ELISA, FCM
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
ELISA1:1000-1:2000
FCM1:25-1:100

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant Human AXL Protein (Catalog#10279-H08H)
宿主/亚型Monoclonal Mouse IgG1 Clone #17
抗体类型Monoclonal
产品类型Antibody
克隆号17
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

特异性

Human AXL

制备方法

This product is a recombinant monoclonal antibody expressed from HEK293 cells.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

Axl receptor tyrosine kinase, together with Tyro3 and Mer, constitute the TAM family of receptor tyrosine kinases. In the nervous system, Axl and its ligand Growth-arrest-specific protein 6 (Gas6) are expressed on multiple cell types. Axl functions in dampening the immune response, regulating cytokine secretion, clearing apoptotic cells and debris, and maintaining cell survival. Axl is upregulated in various disease states, such as in the cuprizone toxicity-induced model of demyelination and in multiple sclerosis (MS) lesions, suggesting that it plays a role in disease pathogenesis. Axl expression correlates with poor prognosis in several cancers. Axl mediates multiple oncogenic phenotypes and activation of these RTKs constitutes a mechanism of chemoresistance in a variety of solid tumors. Axl contributes to cell survival, migration, invasion, metastasis and chemosensitivity justify further investigation of Axl as novel therapeutic targets in cancer. The receptor tyrosine kinase AXL is thought to play a role in metastasis. The soluble AXL receptor as a therapeutic candidate agent for treatment of metastatic ovarian cancer. GAS6/AXL targeting as an effective strategy for inhibition of metastatic tumor progression in vivo. Full Name AXL receptor tyrosine kinase Research Areas Receptor Tyrosine Kinases (RTKs) References Weinger JG, et al. (2011) Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during Experimental Autoimmune Encephalomyelitis. J Neuroinflammation. 8: 49. Linger RM, et al. (2010) Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets. 14(10): 1073-90. Cavet ME, et al. (2010) Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB. Hypertension. 56(1): 105-11. Rankin EB, et al. (2010) AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res. 70(19): 7570-9.